Measuring the epilepsy treatment gap in sub-Saharan Africa

The Lancet Neurology

Volumn 11, Issue 8, 2012, Pages 655-657

  Winkler, Andrea S ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

AFRICA; ANTICONVULSANT THERAPY; EPILEPSY; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HUMAN; LETTER; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT GAP;

ANTICONVULSANTS; EPILEPSY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MEDICATION ADHERENCE;

EID: 84863861202     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(12)70160-6     Document Type: Letter

References (13)

1. Mbuba CK, Ngugi AK, Fegan G, et al. Risk factors associated with the epilepsy treatment gap in Kilfi, Kenya: a cross-sectional study. Lancet Neurol 2012, published online July 6. http://dx.doi.org/10.1016/S1474-4422(12)70155-2.
2. Diop AG, Hesdorffer DC, Logroscino G, Hauser WA Epilepsy and mortality in Africa: a review of the literature. Epilepsia 2005, 46(suppl 11):33-35.
3. Meinardi H, Scott RA, Reis R, et al. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001, 42:136-149.
4. Winkler AS, Kerschbaumsteiner K, Stelzhammer B, et al. Prevalence, incidence and clinical characteristics of epilepsy-a community-based door-to-door study in northern Tanzania. Epilepsia 2009, 50:2310-2313.
5. Coleman R, Loppy L, Walgraven G The treatment gap and primary health care for people with epilepsy in rural Gambia. Bull World Health Organ 2002, 80:378-383.
6. Ndoye NF, Sow AD, Diop AG, et al. Prevalence of epilepsy, its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal, an ILAE/IBE/WHO study. Seizure 2005, 14:106-111.
7. Meyer AC, Dua T, Ma J, et al. Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010, 88:260-266.
8. Birbeck GL Barriers to care for patients with neurologic disease in rural Zambia. Arch Neurol 2000, 57:414-417.
9. Birbeck G, Chomba E, Atadzhanov M, et al. The social and economic impact of epilepsy in Zambia: a cross-sectional study. Lancet Neurol 2007, 6:39-44.
10. Winkler AS, Mayer M, Schnaitmann S, et al. Belief systems of epilepsy and attitudes towards people living with epilepsy in a rural community of northern Tanzania. Epilepsy Behav 2010, 19:596-601.
11. Winkler AS, Mayer M, Ombay M, et al. Attitudes towards African traditional medicine and Christian spiritual healing regarding treatment of epilepsy in a rural community of northern Tanzania. Afr J Trad CAM 2010, 7:162-170.
12. Morisky DE, Green LW, Levine DM Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
13. Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49:1239-1276.